Table 3.

Change in cardiovascular risk factors in women achieving clinically significant weight loss, moderate weight loss or neither

	CWL (≥5.0% WL) (n=47)	MWL (≥3.0% to ≤5.0% WL) (n=43)	No CWL or MWL (<3.0% WL) (n= 240)
ΔWeight (kg)	−7.6 (CI: −8.1 to −7.3)†	−3.5 (CI: −4.1 to −2.9)†	0.04 (−0.2 to 0.3)†
ΔPercent weight loss (%)	−8.9 (CI: −9.6 to −8.3)†	−4.1 (CI: −4.8 to −3.4)†	0.1 (CI: −0.2 to 0.37)†
ΔWaist circumference (cm)	−6.0 (CI: −7.9 to −4.1)*	−3.6 (CI: −5.7 to −1.6)	−2.0 (CI: −2.8 to −1.1)
ΔHigh density lipoprotein (mg/dL)	1.9 (CI: −2.8 to 6.7)	1.0 (CI: −4.1 to 6.0)	−0.1 (CI: −3.2 to 2.9)
ΔLow density lipoprotein (mg/dL)	−3.6 (−15.0 to 7.9)	0.2 (−12.3 to 12.7)	−0.3 (−7.6 to 7.1)
ΔTriglycerides (mg/dL)	−16.7 (CI: −44.8 to 11.5)	−10.1 (−40.4 to 20.2)	3.6 (−14.4 to 21.6)
ΔTotal cholesterol (mg/dL)	−4.8 (CI: −18.5 to 8.9)	−1.6 (CI: −16.5 to 13.4)	0.6 (CI: −8.1 to 9.4)
ΔSystolic blood pressure (mmHg)	−2.9 (CI: −6.4 to 0.6)	1.0 (CI: −2.7 to −4.6)	−0.8 (CI: −2.4 to 0.9)
ΔDiastolic blood pressure (mmHg)	−1.5 (CI: −3.5 to 0.6)	1.7 (CI: −0.4 to 3.9)ζ	0.6 (CI: −0.4 to 1.5)
ΔGlucose (mg/dL)	−2.0 (−3.9 to 0.01)	−2.3 (CI: −4.4 to −0.2)	−1.0 (CI: −1.8 to 0.1)
ΔInsulin (pmol/L)	−13.5 (CI: −22.1 to −5.0)*	−9.4 (CI: −18.1 to −0.6)	−0.6 (−4.3 to 3.1)
ΔVO2 peak (L/min)	0.06 (CI: 0.02 to 0.10)	0.04 (CI: −0.01 to 0.08)	0.07 (CI: 0.05 to 0.09)
ΔNutrient intake (kcals/day)	−637.75 (CI: −599.1 to −367.1)	−427.7 (CI: −717.8 to −137.7)	−637.8 (CI:(−902.4 to −373.1)
Δ Steps	555.8 (CI: 356.0 to 755.6)	672.5 (CI: 222.2 to 1122.8)	657.2 (CI: 237.9 to 1076.6)
Steps during intervention (steps/day)	5530.7 (CI: 5111.4 to 5950.1)	5546.0 (CI: 5095.7 to 5996.3)	5429.3 (CI: 5229.5 to 5629.1)

^*Indicates significant difference compared to no CWL or MWL group;

^ζindicates significant difference between MWL and CWL;

^†indicates all groups significantly different from all groups